Nunung Nurbaeti, Vella Mirfaqoh, Rezki Zulhendra, Yosep Hertanto Amin, Neo Cahyo Alhadi, Ahmad Fadhil, Rifi Hamdani Sitohang, Sri Yusriani
{"title":"PT Kimia Farma, Tbk (Persero) 2021-2022年财务业绩分析","authors":"Nunung Nurbaeti, Vella Mirfaqoh, Rezki Zulhendra, Yosep Hertanto Amin, Neo Cahyo Alhadi, Ahmad Fadhil, Rifi Hamdani Sitohang, Sri Yusriani","doi":"10.33830/isbest.v3i1.1303","DOIUrl":null,"url":null,"abstract":"The effective management of company operations hinges on precise analysis and informed decision-making. Financial reports are pivotal in this decision-making process. In 2022, PT Kimia Farma, Tbk (Persero) registered a net loss, a stark contrast to its performance in 2021. This study aims to assess the financial performance of PT Kimia Farma, Tbk (Persero) during the 2021-2022 period using quantitative descriptive data sourced from financial reports. The employed methodologies include comparative financial statement analysis and financial ratio. Despite the company's robust performance foundation, the findings indicate a decline in its financial performance. The first research on PT Kimia Farma, Tbk (Persero) conducted financial performance during the pandemic or 2020 until 2021. Originality produces financial performance analysis and any suggestions to pharmaceutical companies.","PeriodicalId":187916,"journal":{"name":"Proceeding of The International Seminar on Business, Economics, Social Science and Technology (ISBEST)","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of The Financial Performance of PT Kimia Farma, Tbk (Persero) 2021-2022\",\"authors\":\"Nunung Nurbaeti, Vella Mirfaqoh, Rezki Zulhendra, Yosep Hertanto Amin, Neo Cahyo Alhadi, Ahmad Fadhil, Rifi Hamdani Sitohang, Sri Yusriani\",\"doi\":\"10.33830/isbest.v3i1.1303\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The effective management of company operations hinges on precise analysis and informed decision-making. Financial reports are pivotal in this decision-making process. In 2022, PT Kimia Farma, Tbk (Persero) registered a net loss, a stark contrast to its performance in 2021. This study aims to assess the financial performance of PT Kimia Farma, Tbk (Persero) during the 2021-2022 period using quantitative descriptive data sourced from financial reports. The employed methodologies include comparative financial statement analysis and financial ratio. Despite the company's robust performance foundation, the findings indicate a decline in its financial performance. The first research on PT Kimia Farma, Tbk (Persero) conducted financial performance during the pandemic or 2020 until 2021. Originality produces financial performance analysis and any suggestions to pharmaceutical companies.\",\"PeriodicalId\":187916,\"journal\":{\"name\":\"Proceeding of The International Seminar on Business, Economics, Social Science and Technology (ISBEST)\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceeding of The International Seminar on Business, Economics, Social Science and Technology (ISBEST)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33830/isbest.v3i1.1303\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceeding of The International Seminar on Business, Economics, Social Science and Technology (ISBEST)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33830/isbest.v3i1.1303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
公司运营的有效管理取决于精确的分析和明智的决策。财务报告在决策过程中至关重要。2022 年，PT Kimia Farma, Tbk（Persero）出现净亏损，与 2021 年的表现形成鲜明对比。本研究旨在利用财务报告中的定量描述性数据评估 PT Kimia Farma, Tbk (Persero) 在 2021-2022 年期间的财务业绩。采用的方法包括财务报表比较分析和财务比率。尽管该公司拥有稳健的业绩基础，但研究结果表明其财务业绩有所下降。这是首次对 PT Kimia Farma, Tbk (Persero) 公司在大流行期间或 2020 年至 2021 年的财务业绩进行研究。原创性地对制药公司的财务业绩进行分析并提出建议。
Analysis of The Financial Performance of PT Kimia Farma, Tbk (Persero) 2021-2022
The effective management of company operations hinges on precise analysis and informed decision-making. Financial reports are pivotal in this decision-making process. In 2022, PT Kimia Farma, Tbk (Persero) registered a net loss, a stark contrast to its performance in 2021. This study aims to assess the financial performance of PT Kimia Farma, Tbk (Persero) during the 2021-2022 period using quantitative descriptive data sourced from financial reports. The employed methodologies include comparative financial statement analysis and financial ratio. Despite the company's robust performance foundation, the findings indicate a decline in its financial performance. The first research on PT Kimia Farma, Tbk (Persero) conducted financial performance during the pandemic or 2020 until 2021. Originality produces financial performance analysis and any suggestions to pharmaceutical companies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
